Contact
Phone: 440.312.8422
Fax: 440.312.8224
Email: tassefn@ccf.org
Education
- PGY2 Ambulatory Care Pharmacy Residency 2023. Cleveland Clinic Hillcrest Hospital, Mayfield Heights, OH.
- PGY1 Pharmacy Residency, 2022 Cleveland Clinic Hillcrest Hospital, Mayfield Heights, OH.
- Doctor of Pharmacy 2021, Ohio Northern University, Raabe College of Pharmacy, Ada, OH.
Areas of Interest
- Chronic heart failure.
- Diabetes.
- Asthma and COPD.
- Transitions of care.
Current Projects & Committees
- Member of American College of Clinical Pharmacy.
- American College of Clinical Pharmacy Ambulatory Care PRN.
- Membership Committee Member.
- Member of Ohio Pharmacists Association.
- Member of American Pharmacist Association.
- Member of Ohio College of Clinical Pharmacy.
- Member of the American Society of Health-System Pharmacists.
Publications
- Kallinski J, Xu B, Boyd R, Tasseff N, Rutkowski K, et al. Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review. Am J Cardiovasc Drugs. 2024;24:591–602.
- Tasseff N, Axtell S, Nixon B. Effect of extended pharmacist involvement in discharge transitions of care on hospital readmission rates: Prospective, randomized, parallel arm design trial. J Am Coll Clin Pharm. 2024;7:8–14.
- Tasseff N, Rigelsky F, Fink K, Can Direct Acting Anticoagulants Be Used in Obese Patients? OCCP Newsletter, 2021
- Boyd R, Tasseff N, Xu B. Contemporary review on the management of oral anticoagulation and anti-platelet therapies in patients undergoing percutaneous coronary intervention with concurrent atrial fibrillation. AME Med J 2021;6:31.
Poster Presentations
- Tasseff N, Axtell S, Nixon B. Effect of extended pharmacist involvement in discharge transitions of care on hospital readmission rates. Ohio Pharmacy Resident Conference. Ada, OH. May 2023
- Tasseff N, Axtell S, Nixon B. Effect of extended pharmacist involvement in discharge transitions of care on hospital readmission rates, ASHP Midyear Conference, Las Vegas, NV. December 2022
- Tasseff N, Nixon B, Axtell S. Impact of Glucagon-like Peptide 1 Agonist Therapy on Weight Loss in Type 2 Diabetes Patients. ACCP Global Conference, San Francisco, CA. October 2022
- Tasseff N, Rigelsky F, Joslin B, Newell B. Evaluation of an Argatroban Nomogram. OCCP Spring Meeting, Virtual Meeting, May 2022
Lecture Presentations
- AASHP Business Meeting and Continuing Education - Review of Current Therapies and Updated Guidelines for Dyslipidemias. January 2023, Fairlawn, OH
- APRN Conference, Advance Practice Pharmacology - Review of Current Therapies and Updated Guidelines for Dyslipidemias. November 2022, Beachwood, OH
